Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 153

1.

Scedosporium prolificans pericarditis and mycotic aortic aneurysm in a lung transplant recipient receiving voriconazole prophylaxis.

Sayah DM, Schwartz BS, Kukreja J, Singer JP, Golden JA, Leard LE.

Transpl Infect Dis. 2013 Apr;15(2):E70-4. doi: 10.1111/tid.12056. Epub 2013 Feb 6. Review.

PMID:
23387799
2.

Breakthrough Scedosporium prolificans infection while receiving voriconazole prophylaxis in an allogeneic stem cell transplant recipient.

Tong SY, Peleg AY, Yoong J, Handke R, Szer J, Slavin M.

Transpl Infect Dis. 2007 Sep;9(3):241-3. Epub 2007 Jul 1.

PMID:
17605752
3.
4.

Epidemiology, clinical manifestations, and outcomes of Scedosporium infections among solid organ transplant recipients.

Johnson LS, Shields RK, Clancy CJ.

Transpl Infect Dis. 2014 Aug;16(4):578-87. doi: 10.1111/tid.12244. Epub 2014 Jun 24.

PMID:
24962102
5.
6.

Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome.

Husain S, Muñoz P, Forrest G, Alexander BD, Somani J, Brennan K, Wagener MM, Singh N.

Clin Infect Dis. 2005 Jan 1;40(1):89-99. Epub 2004 Dec 8.

7.

Antifungal prophylaxis with voriconazole or itraconazole in lung transplant recipients: hepatotoxicity and effectiveness.

Cadena J, Levine DJ, Angel LF, Maxwell PR, Brady R, Sanchez JF, Michalek JE, Levine SM, Restrepo MI.

Am J Transplant. 2009 Sep;9(9):2085-91. doi: 10.1111/j.1600-6143.2009.02734.x. Epub 2009 Jul 23.

8.

Infective endocarditis and meningitis due to Scedosporium prolificans in a renal transplant recipient.

Uno K, Kasahara K, Kutsuna S, Katanami Y, Yamamoto Y, Maeda K, Konishi M, Ogawa T, Yoneda T, Yoshida K, Kimura H, Mikasa K.

J Infect Chemother. 2014 Feb;20(2):131-3. doi: 10.1016/j.jiac.2013.09.006. Epub 2013 Dec 11.

PMID:
24462439
9.

Fatal disseminated infection due to Scedosporium prolificans in a patient with acute myeloid leukemia and posaconazole prophylaxis.

Rivier A, Perny J, Debourgogne A, Thivillier C, Lévy B, Gérard A, Machouart M.

Leuk Lymphoma. 2011 Aug;52(8):1607-10. doi: 10.3109/10428194.2011.573034. Epub 2011 Jun 8. No abstract available.

PMID:
21649548
10.

Voriconazole in the treatment of invasive mold infections in transplant recipients.

Fortún J, Martín-Dávila P, Sánchez MA, Pintado V, Alvarez ME, Sánchez-Sousa A, Moreno S.

Eur J Clin Microbiol Infect Dis. 2003 Jul;22(7):408-13. Epub 2003 Jun 24.

PMID:
12827536
11.

Fatal mycotic aneurysms due to Scedosporium and Pseudallescheria infection.

Ong A, Blyth CC, Bency R, Vicaretti M, Harun A, Meyer W, Shingde M, Gilroy N, Chapman J, Chen SC.

J Clin Microbiol. 2011 May;49(5):2067-71. doi: 10.1128/JCM.02615-10. Epub 2011 Mar 23.

12.

Successful control of disseminated Scedosporium prolificans infection with a combination of voriconazole and terbinafine.

Howden BP, Slavin MA, Schwarer AP, Mijch AM.

Eur J Clin Microbiol Infect Dis. 2003 Feb;22(2):111-3. Epub 2003 Feb 14.

PMID:
12627286
13.

Successful outcome of Scedosporium apiospermum disseminated infection treated with voriconazole in a patient receiving corticosteroid therapy.

Muñoz P, Marín M, Tornero P, Martín Rabadán P, Rodríguez-Creixéms M, Bouza E.

Clin Infect Dis. 2000 Dec;31(6):1499-501.

14.
15.

Voriconazole prophylaxis in lung transplant recipients.

Husain S, Paterson DL, Studer S, Pilewski J, Crespo M, Zaldonis D, Shutt K, Pakstis DL, Zeevi A, Johnson B, Kwak EJ, McCurry KR.

Am J Transplant. 2006 Dec;6(12):3008-16.

16.

[Scedosporium apiospermum disseminated infection in a single lung transplant recipient].

Solé A.

Rev Iberoam Micol. 2011 Jul-Sep;28(3):139-42. doi: 10.1016/j.riam.2011.06.007. Spanish.

PMID:
21700235
17.

Preemptive treatment with voriconazole in lung transplant recipients.

Neoh CF, Snell GI, Levvey B, Kotsimbos T, Morrissey CO, Slavin MA, Stewart K, Kong DC.

Transpl Infect Dis. 2013 Aug;15(4):344-53. doi: 10.1111/tid.12071. Epub 2013 Mar 25.

PMID:
23527908
18.
19.

Emerging infectious endocarditis due to Scedosporium prolificans: a model of therapeutic complexity.

Fernandez Guerrero ML, Askari E, Prieto E, Gadea I, Román A.

Eur J Clin Microbiol Infect Dis. 2011 Nov;30(11):1321-4. doi: 10.1007/s10096-011-1212-3. Epub 2011 Apr 1. Review.

PMID:
21455664
20.

Changing epidemiology of rare mould infections: implications for therapy.

Malani AN, Kauffman CA.

Drugs. 2007;67(13):1803-12. Review.

PMID:
17722951
Items per page

Supplemental Content

Write to the Help Desk